IBB biotech fund on track for biggest weekly decline in 7 years

Call a doctor! The biotech sector is on the verge of suffering one of its worst weeks in years after Democratic presidential hopeful Hillary Clinton raised concerns about what she described as “price gouging” by health-care and biotech companies.